The Human Medicines (Amendments Relating to Naloxone and Transfers of Functions) Regulations 2024
These Regulations amend the Human Medicines Regulations 2012 (“the 2012 Regulations”), which govern the arrangements across the United Kingdom for the licensing, manufacture, wholesale dealing and sale or supply of medicines for human use.
Lifecycle
Department
Made
04 Nov 2024
—
In force
02 Dec 2024
Enabling power
In accordance with section 47(3) and (6)(c) of that Act, a draft of these Regulations was laid before Parliament and the Northern Ireland Assembly and approved by a resolution of each House of Parliament and the Northern Ireland Assembly.
DocumentsOpen on legislation.gov.uk →